Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Gerevich, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Gerevich, J.
Related Collections
* Opioids
* Other Addictive Disorders
Psychosomatics 46:189, April 2005
© 2005 The Academy of Psychosomatic Medicine


Letter

Fatal Combination of Ecstasy and Heroin

J. Gerevich, M.D., Ph.D., Budapest, Hungary

TO THE EDITOR: In their article, Jessica R. Oesterheld, M.D., et al.1 stated that the proserotonergic effects of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) can be augmented by ingestion of other proserotonergic drugs (e.g., fluoxetine, amphetamine, tramadol, or lithium). According to them, the most serious cases of central serotonin syndrome can develop with drugs that block both serotonin "exits": reuptake and monoamine oxidase. MDMA-related deaths have been reported from interactions with monoamine oxidase inhibitors.1

The authors did not mention an interesting combination of MDMA/amphetamines and heroin. In one case, the combined action of heroin and amphetamines prevented death.2 In another case, the combination of MDMA and heroin had a lethal outcome. The circumstances of the death (prelethal symptoms of central serotonin syndrome) suggested that MDMA’s proserotonergic effects were augmented by heroin.3 The mechanism of such an action is not clear. Further research is needed to understand how heroin heightens the effect of Ecstasy.

REFERENCES

  1. Oesterheld JR, Armstrong SC, Cozza KL: Ecstasy: pharmacodynamic and pharmacokinetic interactions. Psychosomatics 2004; 45:84–87[Abstract/Free Full Text]
  2. Jorens PG, Heytens L, Demey HE, Andries S, Ricaurte GA, Bossaert L, Schepens PJ: Acute poisoning with amphetamines (MDEA) and heroin: antagonistic effects between the two drugs. Intensive Care Med 1996; 22:456–459[Medline]
  3. Gerevich J, Bácskai E, Kerekes MF, Kiss N, Csorba J: Halálos kimenetel heroin és Ecstasy együtthatás. Adalék a drogok kombinációjából eredo ártalmak kérdéséhez (Combination of heroin and Ecstasy with fatal outcome: contribution on the question of harms arising from the combination of drugs). Psychiatria Hungarica 2000; 15:583–586




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Gerevich, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Gerevich, J.
Related Collections
* Opioids
* Other Addictive Disorders


Get information about faster international access.

Privacy Policy

Copyright © 2005 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org